Lysteda Interactions
There are 61 drugs known to interact with Lysteda (tranexamic acid), along with 5 disease interactions. Of the total drug interactions, 54 are major, 6 are moderate, and 1 is minor.
- View all 61 medications that may interact with Lysteda
- View Lysteda disease interactions (5)
Most frequently checked interactions
View interaction reports for Lysteda (tranexamic acid) and the medicines listed below.
- albuterol
- amitriptyline
- atenolol
- atorvastatin
- azithromycin
- buspirone
- clonazepam
- CoQ10 (ubiquinone)
- cyclobenzaprine
- Cymbalta (duloxetine)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- gabapentin
- ibuprofen
- Lexapro (escitalopram)
- magnesium citrate
- magnesium oxide
- metformin
- omeprazole
- prednisone
- Protonix (pantoprazole)
- Singulair (montelukast)
- tramadol
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Wellbutrin (bupropion)
- Xanax (alprazolam)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Lysteda disease interactions
There are 5 disease interactions with Lysteda (tranexamic acid) which include:
- intravascular clotting/thromboembolism
- subarachnoid hemorrhage
- color vision defect
- convulsions
- renal dysfunction
Report options
QR code containing a link to this page
More about Lysteda (tranexamic acid)
- Lysteda consumer information
- Compare alternatives
- Reviews (70)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
